THE GENETICS OF HSV-1 REACTIVATION
HSV-1 重新激活的遗传学
基本信息
- 批准号:6612665
- 负责人:
- 金额:$ 30.32万
- 依托单位:
- 依托单位国家:美国
- 项目类别:
- 财政年份:2000
- 资助国家:美国
- 起止时间:2000-08-01 至 2005-05-31
- 项目状态:已结题
- 来源:
- 关键词:
项目摘要
Herpes Simplex Virus Type I (HSV-1) infects humans orofacially, causing a gingivostomatis of the mouth and a keratitis of the eye. HSV-1 infections are highly prevalent in the population. Approximately eighty percent of adults in the U.S. are seropositive for HSV-1. Following a primary infection, this virus establishes a latent infection of the trigeminal from which it can reactivate causing a recurrence of the disease. Our present understanding of the pathogenesis of both latency and reactivation at the molecular level is incomplete. Research to date has established the importance of the LAT region in viral reactivation from the latent state. However no clear molecular role for the LAT region's contribution to reactivation has been defined, nor has the role of the LAT region in establishing a latent infection been determined. This proposal is aimed at the construction of more precisely defined mutations within the LAT region. Current viral mutants are defective in more than one function. A second goal of the proposal is to employ a variety of PCR and non-PCR-based techniques to study the ability of these mutant viruses to establish a latency infection when compared with the wild type virus. The final area of interest is to construct recombinant viruses which are unable to reactivate from the latent state and to learn from the structure of those viruses how the LAT region contributes to a reactivation event.
I 型单纯疱疹病毒 (HSV-1) 感染人类口面部,引起口腔牙龈炎和眼睛角膜炎。 HSV-1 感染在人群中非常普遍。美国大约 80% 的成年人 HSV-1 血清呈阳性。原发感染后,该病毒会在三叉神经中建立潜伏感染,并可重新激活,导致疾病复发。 我们目前在分子水平上对潜伏期和再激活发病机制的理解并不完整。 迄今为止的研究已经确定了 LAT 区域在病毒从潜伏状态重新激活中的重要性。 然而,尚未确定 LAT 区域对重新激活的贡献的明确分子作用,也未确定 LAT 区域在建立潜伏感染中的作用。该提案旨在在 LAT 区域内构建更精确定义的突变。 目前的病毒突变体在不止一种功能上存在缺陷。 该提案的第二个目标是采用各种基于 PCR 和非 PCR 的技术来研究这些突变病毒与野生型病毒相比建立潜伏感染的能力。 最后一个感兴趣的领域是构建无法从潜伏状态重新激活的重组病毒,并从这些病毒的结构中了解 LAT 区域如何促进重新激活事件。
项目成果
期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
数据更新时间:{{ journalArticles.updateTime }}
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
数据更新时间:{{ journalArticles.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ monograph.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ sciAawards.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ conferencePapers.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ patent.updateTime }}
LAWRENCE T FELDMAN其他文献
LAWRENCE T FELDMAN的其他文献
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
{{ truncateString('LAWRENCE T FELDMAN', 18)}}的其他基金
HSV-1 GENE EXPRESSION IN LATENCY INFECTED NEURONS
潜伏期感染神经元中的 HSV-1 基因表达
- 批准号:
2442463 - 财政年份:1989
- 资助金额:
$ 30.32万 - 项目类别:
HSV-1 GENE EXPRESSION IN LATENTLY INFECTED NEURONS
潜伏感染神经元中的 HSV-1 基因表达
- 批准号:
2064376 - 财政年份:1989
- 资助金额:
$ 30.32万 - 项目类别:
HSV-1 GENE EXPRESSION IN LATENTLY INFECTED NEURONS
潜伏感染神经元中的 HSV-1 基因表达
- 批准号:
3142782 - 财政年份:1989
- 资助金额:
$ 30.32万 - 项目类别:
HSV-1 GENE EXPRESSION IN LATENTLY INFECTED NEURONS
潜伏感染神经元中的 HSV-1 基因表达
- 批准号:
3142780 - 财政年份:1989
- 资助金额:
$ 30.32万 - 项目类别:
HSV-1 GENE EXPRESSION IN LATENCY INFECTED NEURONS
潜伏期感染神经元中的 HSV-1 基因表达
- 批准号:
2886612 - 财政年份:1989
- 资助金额:
$ 30.32万 - 项目类别:
HSV-1 GENE EXPRESSION IN LATENCY INFECTED NEURONS
潜伏期感染神经元中的 HSV-1 基因表达
- 批准号:
6169973 - 财政年份:1989
- 资助金额:
$ 30.32万 - 项目类别:
相似海外基金
The mechanism of oral carcinogenesis by FAT1 gene mutation
FAT1基因突变导致口腔癌的机制
- 批准号:
23K15977 - 财政年份:2023
- 资助金额:
$ 30.32万 - 项目类别:
Grant-in-Aid for Early-Career Scientists
Development of an efficient method combining quantum chemistry and machine learning to evolve PCR technology and gene mutation analysis
开发一种结合量子化学和机器学习的有效方法来发展 PCR 技术和基因突变分析
- 批准号:
22KJ2450 - 财政年份:2023
- 资助金额:
$ 30.32万 - 项目类别:
Grant-in-Aid for JSPS Fellows
Development of preemptive medicine for asymptomatic MEN1 gene mutation carriers
无症状MEN1基因突变携带者的抢先治疗药物开发
- 批准号:
23H03151 - 财政年份:2023
- 资助金额:
$ 30.32万 - 项目类别:
Grant-in-Aid for Scientific Research (B)
Elucidation of molecular mechanisms of occurrence of anaplastic thyroid cancer using gene mutation analysis and comprehensive gene expression analysis
利用基因突变分析和综合基因表达分析阐明甲状腺未分化癌发生的分子机制
- 批准号:
23K08067 - 财政年份:2023
- 资助金额:
$ 30.32万 - 项目类别:
Grant-in-Aid for Scientific Research (C)
Elucidation of the molecular mechanism of maxillofacial hypoplasia caused by FAT1 gene mutation
FAT1基因突变引起颌面发育不全的分子机制阐明
- 批准号:
22K19629 - 财政年份:2022
- 资助金额:
$ 30.32万 - 项目类别:
Grant-in-Aid for Challenging Research (Exploratory)
Association between CD79B gene mutation and prognosis in vitreoretinal lymphoma
CD79B基因突变与玻璃体视网膜淋巴瘤预后的关系
- 批准号:
22K09763 - 财政年份:2022
- 资助金额:
$ 30.32万 - 项目类别:
Grant-in-Aid for Scientific Research (C)
Gene mutation/expression prediction from clinical images using artificial intelligence technology in pancreatic cancer
利用人工智能技术从临床图像预测胰腺癌基因突变/表达
- 批准号:
20K17570 - 财政年份:2020
- 资助金额:
$ 30.32万 - 项目类别:
Grant-in-Aid for Early-Career Scientists
Elucidation of colorectal carcinogenesis mediated by PTPRK gene mutation
PTPRK基因突变介导的结直肠癌发生机制的阐明
- 批准号:
20K16311 - 财政年份:2020
- 资助金额:
$ 30.32万 - 项目类别:
Grant-in-Aid for Early-Career Scientists
Elucidation of the molecular mechanism of development of anaplastic thyroid cancer using gene mutation analysis and comprehensive gene expression analysis
利用基因突变分析和综合基因表达分析阐明甲状腺未分化癌发生的分子机制
- 批准号:
20K08953 - 财政年份:2020
- 资助金额:
$ 30.32万 - 项目类别:
Grant-in-Aid for Scientific Research (C)
Development of next-generation precision medicine targeting the pathways on which driver gene mutation-positive lung cancer depends
针对驱动基因突变阳性肺癌所依赖的途径开发下一代精准医疗
- 批准号:
20H03771 - 财政年份:2020
- 资助金额:
$ 30.32万 - 项目类别:
Grant-in-Aid for Scientific Research (B)














{{item.name}}会员




